Novo Nordisk to cut weight-loss drug prices by 50%

Name: Novo Nordisk to cut weight-loss drug prices by 50%
Uploaded: 2026-02-24T13:32:17Z
Duration: 24 s
Description: Cheryl Casone reports that Novo Nordisk is set to cut the US list prices for its popular weight-loss drugs Wegovy and Ozempic by up to 50%, starting in January 2027. This move is expected to intensify the price war with competitor Eli Lilly.

Mornings With Maria · FBN · Feb 24, 2026 · 24s

Sign Up Now

Already a subscriber?

Cheryl Casone reports that Novo Nordisk is set to cut the US list prices for its popular weight-loss drugs Wegovy and Ozempic by up to 50%, starting in January 2027. This move is expected to intensify the price war with competitor Eli Lilly.